Colorimetric assessment of BCR-ABL1 transcripts in clinical samples via gold nanoprobes

A review of the European LeukemiaNet recommendations for the management of CML

(2015) Michele Baccarani et al.   ANNALS OF HEMATOLOGY

Gold nanoprobe-based non-crosslinking hybridization for molecular diagnostics

(2015) Miguel Larguinho et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Chronic myeloid leukemia: 2014 update on diagnosis, monitoring, and management

(2014) Elias Jabbour et al.   AMERICAN JOURNAL OF HEMATOLOGY

European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013

(2013) M. Baccarani et al.   BLOOD

Improving access to care in low and middle-income countries: institutional factors related to enrollment and patient outcome in a cancer drug access program

(2013) Ebru Tekinturhan et al.   BMC HEALTH SERVICES RESEARCH

Noble Metal Nanoparticles for Biosensing Applications

(2012) Gonçalo Doria et al.   SENSORS

Dynamics of chronic myeloid leukemia response to long-term targeted therapy reveal treatment effects on leukemic stem cells

(2011) M. Tang et al.   BLOOD

BCR-ABL Transcript Dynamics Support the Hypothesis That Leukemic Stem Cells Are Reduced during Imatinib Treatment

(2011) A. M. Stein et al.   CLINICAL CANCER RESEARCH

Tolerability-Adapted Imatinib 800 mg/d Versus 400 mg/d Versus 400 mg/d Plus Interferon-α in Newly Diagnosed Chronic Myeloid Leukemia

(2011) Rüdiger Hehlmann et al.   JOURNAL OF CLINICAL ONCOLOGY

Scaling up cancer diagnosis and treatment in developing countries: what can we learn from the HIV/AIDS epidemic?

(2010)   ANNALS OF ONCOLOGY

Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS)

(2010) T. P. Hughes et al.   BLOOD

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Expansion of cancer care and control in countries of low and middle income: a call to action

(2010) Paul Farmer et al.   LANCET

RNA quantification using gold nanoprobes - application to cancer diagnostics

(2010) Joao Conde et al.   JOURNAL OF NANOBIOTECHNOLOGY

Flow cytometric immunobead assay for the detection of BCR–ABL fusion proteins in leukemia patients

(2009) F Weerkamp et al.   LEUKEMIA

Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials

(2008) S. Branford et al.   BLOOD

Molecular diagnosis and monitoring in the clinical management of patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors

(2007) Joyce Ou et al.   AMERICAN JOURNAL OF HEMATOLOGY